Dana A. Kennedy
- Pathology and Forensic Medicine top 0.2%
- Oncology top 0.5%
- Dermatology top 0.5%
- Radiology, Nuclear Medicine and Imaging top 1%
- Immunology top 5%
- Co-authors
- Nancy L. BartlettEric L. SieversAndres Forero‐TorresAnas YounesJoseph D. RosenblattJohn P. LeonardRanjana H. AdvaniCarmel M. Lynch
- Topics
- Lymphoma Diagnosis and Treatment (36 papers)Cutaneous lymphoproliferative disorders research (18 papers)CAR-T cell therapy research (14 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Dana A. Kennedy
48 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Pathology and Forensic Medicine 3.0k
- Oncology 2.8k
- Dermatology 929
- Radiology, Nuclear Medicine and Imaging 891
- Immunology 887
Countries citing papers authored by Dana A. Kennedy
This map shows the geographic impact of Dana A. Kennedy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana A. Kennedy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana A. Kennedy more than expected).
Fields of papers citing papers by Dana A. Kennedy
This network shows the impact of papers produced by Dana A. Kennedy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana A. Kennedy. The network helps show where Dana A. Kennedy may publish in the future.
Co-authorship network of co-authors of Dana A. Kennedy
This figure shows the co-authorship network connecting the top 25 collaborators of Dana A. Kennedy. A scholar is included among the top collaborators of Dana A. Kennedy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana A. Kennedy. Dana A. Kennedy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 34 | |
| 7 | Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphomabreakdown → | 1014 |
| 8 | 25 | |
| 9 | 25 | |
| 10 | 160 | |
| 11 | 31 | |
| 12 | 22 | |
| 13 | Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomasbreakdown → | 963 |
| 14 | 27 | |
| 15 | 192 | |
| 16 | 61 | |
| 17 | 24 | |
| 18 | 24 | |
| 19 | Hepatitis B follow-up among Indochinese refugees. | 5 |
| 20 | Prevalence of hepatitis B markers in Indochinese refugees. | 20 |
About Dana A. Kennedy
Dana A. Kennedy is a scholar working on Pathology and Forensic Medicine, Dermatology and Oncology, having authored 50 papers that have together received 4.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (36 papers), Cutaneous lymphoproliferative disorders research (18 papers) and CAR-T cell therapy research (14 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.0k citations), Dermatology (929 citations) and Oncology (2.8k citations). Dana A. Kennedy has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Nancy L. Bartlett, Eric L. Sievers, Andres Forero‐Torres, Anas Younes, Joseph D. Rosenblatt, John P. Leonard, Ranjana H. Advani, Carmel M. Lynch, Joseph M. Connors and Radhakrishnan Ramchandren. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.